HNN3.0
Register
Register
Register

Project cooperationUpdated on 10 January 2026

Increasing the Effectiveness of Antitumor Drugs by Increasing Their Binding to Tumor Tissue Previously Irradiated with Non-Ionizing Microwaves

Associate-Professor

Yerevan, Armenia

About

DNA released from sarcoma 45 tumor (DNAt) and healthy rats (DNAh) in water-saline solution was irradiated during 90 min. The absorption spectra of non-irradiated and irradiated complexes of DNA with anti-tumors drugs doxorubicin (DX) and netropsin (NT) were obtained by spectroscopic method. From the absorption spectra, binding constants К have been calculated. Results: With irradiated tumor DNA, the antitumor drug forms more stable complexes, the binding constant with DX and NT is almost an order of magnitude higher than for non-irradiated DNA, i.e. the same antitumor effect can be expected with much lower doses of drugs, which is actually equivalent to increasing their effectiveness.  Description of the Project: It is necessary to compare the dynamics of changes in tumor growth in three groups of animals: in the control group without radiation, where animals receive a regular course of treatment, and in two (or more) experimental ones, where they receive lower doses and are simultaneously exposed to radiation. If the therapeutic effect is the same in all groups, then this will confirm an increase in the degree of binding of the drug to the irradiated tumor tissue, which is important from the point of view of using gentle methods of treating patients (some patients are forced to interrupt treatment due to their intolerance) and reducing the costs associated with the purchase of expensive drugs (the dosage of drugs is significantly reduced. My role in the consortium: To provide the radio-physical part of the experiment, i.e. to irradiate the studied samples with low-intensity microwaves at selective (bio-resonance) frequencies according to the methodology developed by us. Тype of partner we are looking for: We are looking for a partner who could measure the coefficient (constant) of binding of an antitumor drug to the affected tissue after its irradiation with microwaves.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    Cancer, Fibrosis and Coagulation

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Alessandra Metelli

    Researcher at IRCCS Regina Elena National Cancer Institute

    Rome, Italy

  • Project cooperation

    Crystal structure determination

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Bernhard Spingler

    Prof. Dr. at University of Zurich/ Department of Chemistry/ Phototherapeutics

    Zürich, Switzerland

  • Project cooperation

    Computer Vision for Stem Cells, Tissues, and Molecular Imaging

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Muhammed Akyuzlu

    AI / Computer Vision Engineering at Emoda

    izmir, Türkiye